GALVUS MET - nā ʻōlelo no ka hoʻohana ʻana, ke kumukūʻai, nā loiloi a me nā analog

I loko o ka pūnaewele olakino, hāʻawi ʻia ka lāʻau lapaʻau i loko o ke ʻano o nā papa pālahalaha; e loaʻa ana i kēlā me kēia me ʻelua o nā mea kaha: 50 mg o vildagliptin a me 500, 850 a i ʻole 1000 mg o metformin. Hoʻohana ʻia ka Magnesium stearate, hyprolose, hypromellose, talc, titanium dioxide, macrogol 4000 a me ka mea hoʻoneʻe hao ʻoi ka mea hoʻohana.

Aia i kēlā me kēia kime 10 mau papa. Hoʻopili ʻia nā papa i nā pahu o 3 mau ʻāpana, ua loaʻa iā ia kēlā me kēia pākele he Galvus Met.

Ke kuhikuhi ʻia nei ka lāʻau lapaʻau no ka mālama ʻana, ʻo Galvus Met, a laila lawe ʻia ka lāʻau lapaʻau me ka maʻi maʻamau, a pono pono e inu i ka lāʻau lapaʻau me ka nui o ka wai. Koho ʻia ka nui o ka maʻi no kēlā me kēia maʻi e ke kauka. I kēia hihia, pono e noʻonoʻo i ka ʻoiaʻiʻo loa, ʻaʻole e hoʻonui ka nui o ke ʻano o ka lāʻau lapaʻau ma mua o 100 mg.

I ka hoʻomaka ʻana o nā lāʻau lapaʻau me kēia lāʻau lapaʻau, ua hoʻākāka ʻia ke ʻano e ka ʻimi ʻana iā Vildagliptin a me Metformin. I mea e hoʻopau ʻia ai nā hiʻohiʻona maikaʻi o ka ʻōnaehana o ka hana ʻana i ka wā o ka mālama ʻana, pono ka lawe ʻana i kēia lāʻau me ka meaʻai.

Inā hāʻawi ka lāʻau me Vildagliptin e loaʻa i ka hopena i makemake ʻia, a laila ma kēia hihia, hiki ke kuhikuhi ʻia ʻo Galvus Met ma ke ʻano o ka hopena. I ka hoʻomakaʻana o ke papa o ka lāʻau, pono kahi maʻi o 50 mg 2 mau manawa i kahi lā. Ma hope o kahi manawa pōkole, hiki ke hoʻonui ʻia ka nui o nā lāʻau lapaʻau no ka loaʻa ʻana o ka ikaika.

Inā ʻaʻole i ʻae ʻia ka mālama ʻana me Metformin e hoʻokō pono i kahi hopena maikaʻi, a laila e noʻonoʻo pono i ka ʻano lāʻau i kauoha ʻia i ka wā e hoʻokomo ai ʻo Glavus Met i ka regimen mālama. ʻO ka hopena o kēia lāʻau lapaʻau e pili ana i ka Metoformin hiki iā 50 mg .. 500 mg, 50 mg / 850 mg a i 50 mg / 1000 mg.

Pono ka māhele o ka lāʻau lapaʻau e hoʻokaʻawale i 2 mau dosis. Inā koho ʻia ʻo Vildagliptin a me Metformin i loko o ke ʻano o nā papa i koho ʻia no ke ʻano kumu o ka lāʻau, a laila ua ʻōlelo hou ʻia ʻo Galvus Met, kahi mea e lawe ʻia ma kahi o 50 mg i kēlā me kēia lā.

ʻAʻole pono e hāʻawi ʻia i ka mea maʻi me kēia mea maʻi i nā mea maʻi i hana i nā hana koina, ʻoi aku ka hemahema. ʻO kēia contraindication ma muli o ka loaʻaʻana o ka lāʻau ikaika o kēia lāʻau lapaʻau mai ke kino e hoʻohana ai i nā keiki. Me ka nui o ka makahiki, e hoʻohaʻahaʻa ka hana a nā kānaka. Hiki pinepine kēia i nā mea maʻi i hala i nā makahiki 65 o ka makahiki.

No ka poʻe maʻi i kēia makahiki, ua kuhikuhi ʻia ʻo Galvus Met ma ka palena liʻiliʻi loa, a hiki ke hoʻokaʻa ʻia nei ke ʻano o kēia lāʻau ma hope o ka loaʻa ʻana o ka hōʻoia ke hana mau nā maʻi o ka maʻi. I ka wā e mālama ai, pono e mālama pinepine ke kauka i kā lākou hana.

Nā papaʻuʻuku, 50 mg 500 mg: oval, me nā kihi beveled, hoʻopiʻi ʻoniʻoni, kukui aniani me ka hina puki pinkish. Ma ka ʻaoʻao ʻo NVR ma kēlā ʻaoʻao a aia ʻo LLO ma ka ʻaoʻao.

Nā papaʻuʻuku, 50 mg 850 mg: oval, me nā kihi beveled, ʻoniʻoni a hina ʻia me nā ʻāpana hina hina. Ma kekahi ʻaoʻao ka hōʻailona ʻo "NVR", ma kahi - "SEH".

Nā papaʻi, 50 mg 1000 mg: oval, me nā kihi beveled, hoʻopiʻi ʻia i nā ʻoniʻoni, ʻeleʻele melemele me kahi kāʻei hina. Aia kekahi "NVR" māka ma kekahi ʻaoʻao a me "FLO" ma ka ʻaoʻao.

Aia kekahi mau lālā anuʻu hypoglycemic?

I kēia lā, loaʻa ke kūʻai lāʻau lapaʻau me nā lāʻau lapaʻau, ʻo Galvus a me Galvus i hui. ʻO ka ʻokoʻa nui o Galvusmet ka mea i ʻelua o nā hana ikaika i ka manawa hoʻokahi - metformin a me vildagliptin.

ʻO ka mea hana i ka pā papa ʻaina ka hui ʻoihana lapaʻau Kelemania ʻo Novartis Pharma Production GmbH. Eia kekahi, i loko o nā hale kūʻai hiki ke loaʻa nā huahana like Swiss.

Loaʻa ʻia ka lāʻau lapaʻau i nā palapala papa.

ʻO ka wehewehe ʻana o ka lāʻau lapaʻau i nā ʻōlelo kuhikuhi i ka manaʻo ʻo INN Galvus he vildagliptin, INN Galvus met is vildagliptin metformin.

Ma mua o ka lawe ʻana iā Galvus Met, pono ia e mālama pono i nā ala o kēlā lāʻau lapaʻau i ka manawa i loaʻa mai nei.

Ua hālāwai ʻo Galvus me 50 500 papa papaʻa
Ua loaʻa iā Galvus nā papa he 50 i loko o nā papa hoʻopihapiha,
ʻO Galvus Met 50 1000 papa papaʻa.

No laila, ʻo ka helu helu mua e hōʻike i ka helu o nā milligrams o ka māhele ikaika o ka vildagliptin, ʻo ka lua ka mea e hōʻike ai i ka pae o ke metformin hydrochloride.

Ke kaukaʻi nei i ka hoʻokumu ʻia o nā papa a me kā lākou dosage, ua kau ke kumukūʻai o kēia lāʻau lapaʻau. ʻO ke kumukūʻai kumukūʻai o Galvus meth 50 mg / 500 mg mea ma kahi o hoʻokahi a me ka hapa mau tausani rubles no kanakolu papa. Eia kekahi, hiki iā ʻoe ke kūʻai i kahi lāʻau a me nā ʻāpana he 60 i kēlā me kēia pēpē.

Hoʻohana i ke wā kamaliʻi

Contraindication: ʻo ka makahiki a hiki i 18 mau makahiki (ʻaʻole i hoʻokū ʻia ka hopena a me ka palekana).

ʻAʻoheʻike i loaʻa i ka lāʻau lapaʻau ma waena o nā poʻe maʻi ma lalo o ka makahiki ʻumikumamāwalu makahiki, no laila, ʻaʻole ia ke manaʻo e hoʻokomo i loko o ka lāʻau lapaʻau.

ʻAʻole pono nā poʻe i ʻoi aku ma mua o 65 mau makahiki i ke hoʻoponopono ʻana a me ka hoʻoponopono hou nui no ka hoʻohana ʻana i kēia lāʻau lapaʻau, akā ma mua o ka hoʻohana ʻana, pono ʻoe e kamaʻilio me kahi endocrinologist, kiaʻi pinepine i nā mea āpau a me nā pēpē, a nānā i nā pae o ka glucose koko.

No nā mea maʻi ma lalo o ka 18 mau makahiki o Galvus, ua contraindicated.

I ka wahine hāpai a me nā lactating

Hoʻopili ʻia ke hoʻohana ʻana o Galvus Met 50/1000 mg i ka wā hapai, no ka mea, ʻaʻole i lawa nā ʻike ma ka hoʻohana ʻana i kēia lāʻau lapaʻau i kēia manawa.

Inā pilikia ka glucose metabolism i ke kino, a laila hiki i ka wahine hāpai ke piʻi ka nui o ka hoʻomohala ʻana i nā anomalies congenital, make, a me ka pinepine o nā maʻi neonatal. I kēia hihia, pono e lawe ʻia ka monotherapy me ka insulin e hoʻomaʻamaʻa i ka glucose.

Ua hoʻohana ʻia ka hoʻohana ʻana i ka lāʻau lapaʻau i nā makuahine hānai, no ka mea ʻaʻole i ʻike ʻia inā ua hoʻopili ʻia nā mea o ka lāʻau (vildagliptin a me ka metformin) i loko o ka waiū umauma o ke kanaka.

ʻŌpū a me ka lactation

ʻO nā hoʻokolohua ma nā holoholona hānai, i hāʻawi ʻia he dosis o vildagliptin he 200 mau manawa i ʻoi aku ma mua o ka mea maʻamau, ka mea i hōʻike ʻole ʻia ai ke kinipopo i ka hoʻomohala ʻana i ka embryos a ʻaʻohe i kahi hopena teratogenic. ʻO ka hoʻohana ʻana o Galvus Meta i loko o kahi waihona o 1/10 e hōʻike ana i kahi hopena like.

Ma nā hoʻokolohua hoʻokolohua ma nā holoholona me ka hoʻohana ʻana i vildagliptin i nā wai he 200 mau manawa iʻoi aku ma mua o ka mea i makemake ʻia, ʻaʻole i hoʻokō ʻia ka lāʻau lapaʻau i ka hoʻomohala mua ʻana o ka embryo a ʻaʻohe hopena teratogenic. Ke hoʻohana nei i vildagliptin i hui pū me ka metformin ma kahi hapa o 1:10, ʻaʻole i ʻike ʻia kahi hopena teratogenic.

No ka mea ʻaʻohe ʻike pono o ka hoʻohana ʻana i ka lāʻau Galvus Met i loko o nā wahine hāpai, ua contraindicated ka hoʻohana ʻana o ka lāʻau lapaʻau i ka wā hapai.

Hōʻike nā hōʻike hoʻokolohua i ka hapa nui o ka lāʻau lapaʻau ʻaʻole i hoʻopilikia i ka hoʻomohala ʻana o ka embryo. ʻAʻole loaʻa nā hōʻailona o ka wahine hānai.

ʻAʻole nō i mālama ʻia nā haʻawina hou aku, no laila, mai hoʻopilikia hou i ke ola o ka makuahine a me ke keiki. He mea koʻikoʻi e hoʻomanaʻo inā he kuhihewa i ka hoʻokaʻina o ke kō, e pili ana i ka maikaʻi o nā kelepona o ka male āpau, a me ka hopena o ka hoʻāla ʻana a me ka hoʻonui i ka morbidity neonatal.

ʻAʻole kuhikuhi ʻia ʻo Galvus i ka wā hāpai / lactation.

Ke waiho nei i nā hōʻike ʻana a me ke kumu kūʻai o ka lāʻau lapaʻau

Wahi a nā ʻōlelo kuhikuhi, e kūpono ke hoʻohana ʻana o Galvus Met i loko o 18 mau mahina mai ka lā o ka hoʻokuʻu ʻana, e pili ana i ka mālama pono. Pono e hoʻokaʻawale ʻia nā lāʻau lapaʻau. He wahi ʻeleʻele a maloʻo ʻole i hiki ke nānā ʻia i ka nānā ʻana o nā keiki e kūpono no ka mālama ʻana, me nā kūlana wela a hiki i 30 ° C.

Hoʻokuʻu ʻia kahi lāʻau lapaʻau. No ka lāʻau lapaʻau ʻo Galvus Met, ke hoʻoholo nei ke kaukona i ke kumukūʻai:

50/500 mg - ka awelika o 1457 mau rubles,
50/850 mg - ka awelika o 1469 rubles,
50/1000 mg - kahi awā o 1465 rubles.

ʻOiai me ka hoʻohana pono ʻana i kēlā me kēia lā, ʻaʻole pau ka maʻi maʻi maʻi āpau me kēia kumukūʻai, ʻo ka hapa nui o nā hoʻopiʻi a pau mai nā penikala me nā uku liʻiliʻi. Eia nō naʻe, ʻokoʻa mau nā huahana o ka hui ʻo Swissart Novartis Pharma e ko lākou ʻano impeccable, ʻaʻole ia mea i loko o ka waihona kālā o nā mākeke hypoglycemic.

Nā papaʻu papa Galvus

ʻO ka maʻi maʻamau o Galvus e like me ka monotherapy a i hui pū paha me metformin, thiazolinediones a i ole insulin - 2 mau manawa i kahi lā, 50 mg, kakahiaka a me ke ahiahi, me ka manaʻo o ka komo ʻana o ka meaʻai. Inā hoʻoholo ʻia ka mea maʻi i kahi mahele o 1 papa o ke 50 mg i ka lā, a laila e lawe i ke kakahiaka.

Vildagliptin - ka hana ikaika o ka lāʻau no ka maʻi Galvus - ua hoʻopiʻi ʻia e nā keiki, akā ma ke ʻano o ka metabolite kā ʻole. No laila, i ka hoʻomaka mua o ka pilikia ʻole, ʻaʻole pono ke loli ka nui o ka lāʻau.

Inā he mau hewa hōʻeha o ka hana o ka ate (ALT a i ʻole nā huina o AST i 2.5 mau manawa ma mua o ka palena palena o ka maʻamau), a laila e kuhikuhi pono ʻia ʻo Galvus. Inā ulu ka mea maʻi i ka jaundice a i ʻole nā hoʻopiʻi kūpaʻa ʻē aʻe, e hoʻopau koke i ka vildagliptin therapy.

No nā maʻi maʻi i ka makahiki 65 a keu aku - ʻaʻole i loli ka nui o Galvus inā ʻaʻohe concomitant pathology. ʻAʻohe ʻikepili e pili ana i ka hoʻohana ʻana i kēia lāʻau lapaʻau maʻi i nā keiki a me nā ʻōpio i lalo o 18 makahiki o kona mau makahiki. No laila, ʻaʻole ia e kuhikuhi ʻia e kuhikuhi i nā mea maʻi i kēia ʻano makahiki.

Pehea e mālama ʻia ai no ka maʻi maʻamau o ka type 2: kahi kaila kiʻekiʻe
Nā lāʻau maʻi maʻi 2: ʻatikala kikoʻī
Siofor a me nā pā Glucofage
Pehea e aʻo ai eʻoliʻoli i ka hoʻonaʻauao kino

Hoʻohālikelike i ka hopena o ka Sugar

ʻO ka hopena haʻahaʻa hilo o ka vildagliptin i hoʻopaʻa ʻia ma kahi hui o 354 nā mea maʻi. Ua hoʻohuli ʻia ka monotherapy galvus i loko o nā hebedoma 24 i alakaʻi i ka nui o ke kahe koko i loko o kēlā mau maʻi i loaʻa ʻole iā lākou i ka maʻi o ka maʻi 2. ʻO kā lākou helu hemoglobin glycated i hōʻemi e 0.4-0.8%, a ma ka hui plasebo - ma ka 0.1%.

Nā hōʻailona no ka hoʻohana ʻana

Pono e hoʻohana ʻia ai ka hoʻohana ʻana i ka lāʻau lapaʻau e nā kauka hele mai. Hiki wale i kahi mea lapaʻau ke koho pololei i ka ʻano o ka lāʻau lapaʻau hypoglycemic, e pili ana i ke kūlana o ka pathology.

Ke lawe nei i ka lāʻau lapaʻau, pono ʻoe e makaʻala i ka mālama pono a mālama pono i nā pae koko koko. ʻO ke koho kūpono, ʻo ia hoʻi ma ke kānāwai, ʻaʻohe hopena maikaʻi loa o ke kino o ka mea maʻi.

Hoʻohana pinepine ʻia ka hoʻohana ʻana i ka lāʻau, me ka ʻole o ka huki, akā me ka nui o ke ʻano o ka wai.

Hōʻike ʻia ka loaʻa ʻana o Galvus Meta i nā pilikia aʻe:

me ka maʻi diabetes type 2, ke pau ʻole nā koho lapaʻau ʻē aʻe,
i ka hihia o ka launa ʻole pono me ka metformin a vildagliptin e like me nā mea hoʻokaʻawale,
i ka mea i hoʻohana mua ka mea maʻi i nā lāʻau lapaʻau me nā ʻāpana like,
no ka mālama paʻakikī ʻana i ka maʻi lolo me nā lālani hypoglycemic a i ʻole insulin.

Nā hōʻailona no ka maʻi maʻamau 2 - wikiō

Aia ka lāʻau lapaʻau i ka papa inoa o nā contraindications:

ke hoʻomaloka ʻana i nā ʻāpana
maʻi diabetes type 1
palaka paleka, naʻe palu,
nā hana ʻoihana o nā maʻi hopohopo e hoʻopili ana i ka hoʻopunipuni o nā ʻōpū (kuʻi, ke kuni, ke maʻi hypoxia, ke nānā ʻana, nā kaʻai o ka maʻi o ka papa)
nā huaʻehā a me ke ʻano paʻa o ka puʻuwai a me nā pilikia cardiovascular,
alokino
nā meaʻai haʻahaʻa-haʻahaʻa (emi iho ma lalo o 1 tausani kcal i ka lā),
metabolic acidosis, diabetes ketoacidosis,
lactic acidosis, hōʻiliʻili o ka lactic acid.

ʻAʻole hoʻohana ʻia ka lāʻau no 2 mau lā ma mua a ma hope o ka interventions, x-ray a me nā haʻawina radioisotope. Mai hoʻohana no ka mālama ʻana i nā keiki a me nā ʻōpio ma lalo o 18 makahiki o nā makahiki he nui, nā wahine hāpai a me nā lactating, no ka mea, ʻaʻole i hoʻokō pono.

No ka poʻe ma luna o 60, hiki ke kiʻi ʻia i ka lāʻau lapaʻau ma lalo o ka mākaʻi loea. Eia kekahi, ke kuhikuhi pono nei lākou i ka poʻe nāna e pili me ka hana hoʻoikaika kino. I kēia hihia, hoʻonui ʻia ka loaʻa o ka acidosis lactic.

Kahi ʻia ka koho ʻana o ka dosage pākahi. Ke hilinaʻi nei i ke kōpaʻa o ke kō, hiki ke hana i mua o ka lāʻau mua a me ka loaʻa ʻana o ka hoʻomanawanui i ka lāʻau.

No ka hoʻēmi ʻana i ka hopena o ka hopena mai ka gastrointestinal tract, pono ʻia e inu i nā papa me ka meaʻai. ʻAʻole ʻae a ʻōwī paha a ʻohi paha, inu wale i ka wai nui.

Ma ke ʻano he kānāwai, lawe ʻia ka nui o ka hopena ma hope o ka hoʻopaʻa ʻana i ka pono o ka pono o kēia manawa. Inā aia ke kanaka i kahi ʻōlohelohe i ke koʻikoʻi, ke kaumaha a me ke kaumaha paha, e hoʻemi ʻia paha ka hopena o Glavus Met.

Me ka hoʻomanawanui lōʻihi me ka lāʻau lapaʻau, pono ia e hana i kahi hōʻike koko ākea ma kahi o hoʻokahi makahiki. E pale aku i nā hopena maikaʻi ʻole i ke kino a hana i nā manawa kūpono e hoʻopau iā lākou.

ʻO Galvus Met, ʻaʻole like me nā lāʻau like like, hiki ke hoʻohui pū me ka insulin. Ua ae ʻia ia e hoʻohana pū me ia me ka hoʻohana ʻana i kekahi mau lāʻau lapaʻau hypoglycemic ʻē aʻe.

Nui! I ka hui pū ʻana me kekahi mau lāʻau lapaʻau (hoʻohālikelike i ka waha, diuretics), e loli paha ka hopena o Galvus Met. Pono e noʻonoʻo pono kēia inā pono nā ala ʻē aʻe.

Ke koho ʻana i ka lāʻau lapaʻau Galvus, ʻae nā kuhikuhi no ka hoʻohana ʻana e ʻike i ka mea maʻi e ʻike i nā hōʻailona no ka hoʻohana ʻana i kēia lāʻau mālama. ʻO ka mea nui ka type diabetes 2

ʻo kēia lāʻau lapaʻau ka mea wale nō i hiki ke hāʻawi i kahi hopena mau loa i ka mālama ʻana i kēia maʻi. Hāʻawi ʻia, eia ke hoʻolako ʻia inā, ma kahi o nā lāʻau lapaʻau, e hāhai ʻia kahi papaʻaina, a ma kahi ʻē aʻe i kēia, ke ola o ka mea maʻi ma ka nui o ke ʻano me ka hana pilikino,
hoʻohana i kēia mea hana i ka hana me Metformin ma ka hoʻomaka mua o ka lāʻau lapaʻau, i ka wā eʻai ai, a me ka hoʻonui ʻana o ka nui o nā hana pilikino, ʻaʻole i lawe mai i ka hopena i makemake ʻia,
ua hoʻohālikelike ʻia i nā poʻe maʻi i hoʻohana i nā mea pili i kēia lāʻau lapaʻau i loaʻa nā mea like me ka vildagliptin a me ka metformin,
no ka hana paʻakikī e hoʻohana ana i nā lāʻau e pili ana i ka vildagliptin a me ka metformin e like me nā mea nui, a me ka hoʻopiʻi ʻana o ka sulfonylurea a i ʻole derivatives insulin i loko o ka hoʻoponopono regimen,
Hoʻohana ʻia ʻo Galvus i nā hihia kahi haʻahaʻa loa ka hopena o ka monotherapy, a no ka mea eʻai ai a me ka loaʻa ʻana o nā hana kino ma ke ola o ka mea maʻi e hāʻawi i kahi hopena i makemake ʻia,
ma ke ʻano he lāʻau triple, inā ʻo ka hoʻohana ʻana i nā lāʻau lapaʻau e pili ana i ka sulfonylurea a me nā derivatives metformin, i hoʻohana ʻia ma mua, hāʻawi ʻia e ka mea maʻi i kekahi kīʻai a me ke komo ʻana i ka nui o ke kino pilikino, ʻaʻole i hoʻolako i nā hopena i makemake ʻia.
ma ke ʻano he lāʻau triple, i ka wā o ka hopena o nā lāʻau i hoʻopili ʻia e pili ana i ka metformin a me ka insulin, ma lalo o nā kūlana o kekahi meaʻai a me ka hana kino, ua haʻahaʻa.

Ma hope o ke kūleʻa ʻana, koho ka ʻokoʻa kūikawā i kahi ʻano o nā lāʻau lapaʻau no ka mālama ʻana i ka maʻi maʻi. Ke koho nei i ka dosis o ka lāʻau, ke kū nei ia i ka nui o ke ʻano o ka maʻi, a noʻonoʻo pū kekahi i ke ahonui o ka lāʻau.

ʻAʻole hiki ke alakaʻi ʻia ka mea maʻi e kahi pāʻina i ka wā o Galvus therapy. ʻO nā mea e pili ana i nā loiloi ʻo Galvus e hōʻike nei ma hope o ka loaʻa ʻana o ka maʻi diabetes type 2, ʻo nā mea loea mua ka mea e kuhikuhi ai i kēia lāʻau hoʻoponopono.

Ke hoʻokō nei i nā maʻi paʻakikī, e pili pū me ka metformin, thiazolidinedione a i ʻole insulin, ua lawe ʻia ʻo Galvus i loko o kahi waihona ʻo 50 i ka 100 mg i kēlā me kēia lā.I ka hopena i hōʻemi ʻia ke ʻano o ka mea maʻi, a laila hoʻohana ʻia ka insulin e hōʻoia i ka hoʻokū ʻana o nā waiwai o ka kō koko koko. I kēlā mau hihia, ʻaʻole pono nā mea o ka nui o ka lāʻau lapaʻau ma mua o 100 mg.

Ke kau nei ke kauka i kahi hoʻoponopono lapaʻau e pili ana i ka lawe ʻana i kekahi mau lāʻau lapaʻau, no ka laʻana, Vildagliptin, sulfonylurea derivatives a me Metformin, a laila ma kēia ke ʻano o ka papa i kēlā me kēia lā he 100 mg.

Hāpai nā poʻe loea no ka wehe maikaʻi ʻana o ka maʻi e Galvus e lawe i ka wai lāʻau o 50 mg o ka lāʻau i ka manawa hoʻokahi i ke kakahiaka. Kaukaʻi nā kauka i ke hoʻokaʻawale ʻana i ka nui o 100 mg i loko o ʻelua iniha.

Pono ʻia ka 50 mg i ke kakahiaka a me ka nui o ka lāʻau lapaʻau i ke ahiahi. Inā haʻalele ka mea maʻi i ka lāʻau lapaʻau no kekahi kumu, a laila hiki ke hana ʻia kēia i ka hiki.

E hoʻomaopopo, ʻaʻole i loaʻa i kahi nui i hoʻoholo ʻia e ke kauka.

Ke hōʻike ʻia kahi maʻi me nā mea ʻelua a keu paha, ʻaʻole pono ka nui o ka lā i kēlā me kēia lā he 50 mg. ʻO kēia no ka mea i ka manawa i hoʻopiʻi ai iā Galvus, ua lawe pū ʻia kekahi mau lāʻau ʻē aʻe, e hoʻomaikaʻi hou ʻia ka hana o ka lāʻau lapaʻau nui. I kēlā mau hihia, he kaulia o kahi o 50 mg ka pilina me 100 mg o ka lāʻau i ka wā o ka monotherapy.

Inā ʻaʻole e hāʻawi ka mālama i ka hopena i makemake ʻia, e hoʻonui nā mea aʻoaʻo i ka nui i 100 mg i kēlā me kēia lā.

ʻO kahi analog e loaʻa ka like pū o ka pūnaehana like o ka hana ʻo Galvus Met. Me ia mea, kuhikuhi pinepine nā kauka iā Vildaglipmin.

Hoʻomaopopo ʻia nā hoʻomākaukau e pili ana i ka metformin e mālama me ka mālama ʻana i nā poʻe maʻi ma luna o 60 mau makahiki i ka wā e hana ai i ka hana kino kino, ma muli o ka hoʻonui nui o ka hoʻomohala ʻana i ka acidact lactic i loko o lākou.

Hoʻohana ʻia ka lāʻau lapaʻau e mālama i ka lua o ka maʻi mellitus maʻi lua:

me ka monotherapy, i hui pū ʻia me kaʻai a me ka hoʻoikaika kino,
no nā poʻe maʻi i mālama ʻia ma mua me ka metformin a me vildagliptin e like me ke ʻano lāʻau hoʻokahi,
i ka hoʻomaka mua o ka lāʻau lapaʻau, e hui pū me ka metformin (i ka haʻalele ʻole o ka hopena o ka physiotherapy a me kaʻai ʻana).
i ka hui pū me sulfonylurea, insulin, metformin me ka hana ʻole o ka physiotherapy, kaʻai ʻana a me ka monotherapy i kēia mau lāʻau lapaʻau,
me ka metformin a me sulfonylurea no kēlā poʻe maʻi i hana i ka lāʻau hui mua me kēia mau lāʻau a ʻaʻole i hoʻokō i ka mana glycemic,
e hui pū me ka insulin a me metformin no kēlā poʻe maʻi i hana i ka lāʻau hui ʻana i mua o kēia mau lāʻau a ʻaʻole i hiki i ka mana glycemic.

Hōʻike ʻia kēia ma o ka hōʻike aʻoaʻo no Galvus Met.

ʻO ka nui o ka pauku lāʻau no ka lāʻau Galvus Met e pono ke koho pono ʻia, e pili ana i ka kūpono a me ke kūpaʻa o ka maʻi. Ke hoʻohana nei iā Galvus Met, ʻaʻole iʻoi aku ma kahi o ka nui o ka lā i ʻōlelo ʻia no ka vildagliptin (100 mg).

Pono e koho ʻia i ka lāʻau i ʻōlelo ʻia ai ʻo Galvus Met, e noʻonoʻo ana i ka lōʻihi o ka papa o ka maʻi diabetes a me ka pae o ka glycemia, ke ʻano o ka mea maʻi a me ka hoʻoponopono ʻia ʻana o ka vildagliptin a me / a me ke metformin i hoʻohana mua i ka mea maʻi. No ka hoʻēmiʻana i ka paʻakikī o nā hopena ʻaoʻao mai ka digestive tract, ʻano ʻano o ka metformin, ua lawe ʻia ʻo Galvus Met me ka meaʻai.

ʻO ka hopena kumu o ka lāʻau Galvus Met me ka loaʻa ʻole o ka monotherapy me vildagliptin

Hiki ke hoʻomaka ʻia ka hoʻomaʻamaʻa ʻia me 1 papa. (50 mg 500 mg) mau manawa 2 i ka lā, ma hope o ka loiloi ʻana i ka hopena therapeutic, hiki ke hoʻonui mālie ʻia ka lāʻau.

ʻO ka ʻōlelo kumu mua o ka lāʻau Galvus Met me ka loaʻa ʻole o ka monotherapy me ka metformin

Wahi a ka mole o ka metformin i lawe mua ʻia, hiki ke hoʻomaka me ka lāʻau ʻo Galvus Met me kahi papa 1 papa. (50 mg 500 mg, 50 mg 850 mg a 50 mg 1000 mg) 2 mau lā i ka lā.

ʻO ka hopena mua o ka lāʻau Galvus Met i loko o nā mea maʻi i loaʻa i ka hui hoʻohui pū me vildagliptin a me ka metformin i ke ʻano o nā papa i hoʻokaʻawale.

ʻO ka hiʻona ʻana o ka vildagliptin a i ʻole ka metformin i lawe ʻia, mālama ʻia ʻo ka ʻoihana me Galvus Met me kahi papa e kokoke loa ana i ka ʻano ʻana o ka ʻimi ʻana i ka maʻi (50 mg 500 mg, 50 mg 850 mg a 50 mg 1000 mg), a hoʻoponopono i ka ʻōpū ma muli o ka pono . ^ E Ha yM.

Initial dosis o Galvus Met me kahi hoʻomaka hoʻomaka i nā poʻe maʻi me ka type 2 diabetes mellitus me ka lawa ʻole o ka hoʻomaʻamaʻa ʻana o ka mālama ʻana i ka papa meaʻai a i ka hana

E hoʻomaka ana i ka hoʻomaka ʻana, e hoʻohālikelike ʻia ʻo Galvus Met ma kahi inika mua o 50 mg 500 mg 1 mau lā i ka lā, a ma hope o ka loiloi ʻana i ka hopena therapeutic, e hoʻonui mālie ka nui o ka make i 50 mg 1000 mg 2 mau manawa i ka lā.

Hoʻohui hui me Galvus Met a me nā derivatives o sulfonylurea a i ʻole insulin

Kuhi ʻia ka helu o Galvus Met ma ke kumu o ka maʻi vildagliptin 50 mg × 2 mau lā i kahi lā (100 mg i kēlā me kēia lā) a me ka metformin i loko o kahi pane e like me ia ma mua o ka lāʻau hoʻokahi.

Hola paʻa kino hana. I nā mea maʻi me ka hana renal impaired, hoʻoponopono ʻia ka hoʻoponopono ʻia me Cl creatinine (i helu ʻia e ka ʻoihana Cockcroft-Gault) ma waena o 60 i ka 90 ml / min pono e koi ʻia. ʻO ka hoʻohana ʻana i ka lāʻau Galvus Met i loko o nā mea maʻi me Cl creatinine